Phibro Animal Health | PAHC - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Align Technology USD 4.15B 100.27M 2026-03
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Henry Schein USD 3.27B 21M 2026-03
Idexx Laboratories USD 1.56B 49.28M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Merck USD 45.88B 6.73B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Pacira USD 653.89M 39.22M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.89B 58.06M 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Zoetis USD 3.23B 98M 2026-03